NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: C000000459

Registered date:01/08/2006

Expression profiling of clinical stage II/III esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy.

Basic Information

Recruitment status Complete: follow-up continuing
Health condition(s) or Problem(s) studiedclinical stage II/III esophagel squamous cell carcinoma
Date of first enrollment2005/06/01
Target sample size120
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeFind the gene expression patterns and make programs which predict efficacy of definitive CRT and confirm its accuracy.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum75years-old
GenderMale and Female
Include criteria
Exclude criteria(1) Tumor invasive to the cervical esophagus or gastric cardia with endoscope (2) Patients who have infectionous disease (type B and C hepatitis virus, human immunodeficiency virus, syphilis) and their carrier (3) Patients who are suffered infection and inflammation (4) No other severe medical conditions and patients who are pregnant or breast-feeding (5) Any other inappropriate state for participating to this study estimated by physician

Related Information

Contact

public contact
Name Keiko Minashi
Address 6-5-1, Kashiwanoha, Kashiwa, Chiba, Japan Japan
Telephone 04-7133-1111
E-mail
Affiliation National cancer center hospital east Department of gastroenterology and GI oncology
scientific contact
Name Manabu Muto
Address 54 Kawaharacho, Shogoin, Sakyo-ku, Kyoto, Japan Japan
Telephone 075-751-4592
E-mail
Affiliation University of Kyoto Graduate School of Medicine Department of Gastroenterology and Hepatology